American Chemical Society

Washington, DC Professional servicesNAICS 541990

Self-funded health planPlan year 2025Renews January
1,907Participants+1% vs. prior year
$4.5MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#1 of 6Professional services in DCBy participants

Overview

American Chemical Society sponsors a self-funded health plan that covered 1,907 participants in plan year 2025, about the same as the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,907 · prior year 1,896
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
American Chemical Society Welfare Benefit Plans, plan 503 (1,907 participants)
Stop-loss carrier
Reliastar Life Insurance Company
Broker compensation
$179K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityPrepaid legalLong-term disabilitySeveranceDeath benefitsOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Humana Insurance CompanyMedical1,013$2.7M—
Prudential Insurance Company of AmericaLife, Long-term disability1,813$2.1M$93K
Reliastar Life Insurance CompanyStop-loss3,926$1.2M$76K
Legal ResourcesLegal458$99K—
Inova Employee AssistanceEmployee Assistance Program2,093$45K—
Unum Life Insurance Company of AmericaCritical Illness, Group Long Term Care32$42K$131
Provident Life and Accident Insurance CompanyWhole Life58$29K$7K

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$4.5M/ year

Estimated prescription spend: 1,907 participants × $2,371 national average per member. Usually higher once dependents are counted.

$118K–$290K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$34K–$86K
Lower-cost therapeutic alternatives$50K–$105K
Generic pricing vs. actual cost$22K–$65K
PBM contract terms$11K–$34K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
American Chemical Society
Sponsor EIN
53-0196572
Plan number
503
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 53-0196572 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
American Chemical Society Erisa 403(b) Plan
Type
401(k) plan
Participants
2,568

About this data

Source: American Chemical Society's Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with American Chemical Society.

Request a correction · Methodology